TOKYO, September 23 (Reuters) : Fujifilm Holdings Corp said on Wednesday a late-stage study of its antiviral drug Avigan showed it reduced recovery times for COVID-19 patients with non-severe symptoms, boosting
Friday, 23rd January, 2026
Support The Morung Express. Your Contributions Matter Click Here
Health
Chandigarh, September 22 (IANS): Punjab's three Government Medical Colleges will participate in the Phase-3 trials of Bharat Biotech Ltd's Covaxin, the first indigenously-developed vaccine candidate aga
RIO DE JANEIRO, September 22 (Reuters) - A new study that analyzed the coronavirus outbreak in Brazil has found a link between the spread of the virus and past outbreaks of dengue fever that suggests exposure t
London, September 21 (IANS): A drug used to treat breast and ovarian cancer can extend the lives of some men with prostate cancer, showed results of a major trial which could change clinical practice. Final
Moscow, September 21 (IANS): More than 60,000 people have applied to volunteer for the coronavirus vaccine trials in Moscow and over 700 people have been injected with the coronavirus vaccine, the media reporte
New York, September 20 (IANS): A team of US researchers has found that certain treatments for cancer may increase the chance of death if they contract Covid-19. The study by the researchers at the University
New Delhi, September 20 (IANSlife): Heart failure is one of the most under-diagnosed heart diseases in our country, contributing to a high number of death rates. The National Heart Failure Registry recently rev
London, September 19 (IANS): Scientists have identified a new drug that could prevent or mitigate the consequences derived from infection by SARS-CoV-2, the virus responsible for Covid-19. Preliminary result
New Delh, September 19 (PTI): The Phase 3 human clinical trial of the COVID-19 vaccine developed by Oxford University and being manufactured by the Serum Institute of India (SII) will begin at the Sassoon Gener
London, September 19 (IANS): If you have had a tiring week, just 10 minutes of simple massage at home can do wonders to rejuvenate your mind and body, suggests a new research. All you need to do is find some
New Delhi, September 18 (IANSlife): The original thought was that the novel coronavirus is a respiratory disease, but as the number of patients who have contracted the virus are increasing, it has become clear
Reuters Here's what you need to know about the coronavirus right now: Past the 30 million mark Global coronavirus cases exceeded 30 million on Thursday, according to a Reuters tally, with the pande
September 18 (Reuters) - Pfizer Inc is betting that its coronavirus vaccine candidate will show clear evidence of effectiveness early in its clinical trial, according to the company and internal documents revie
NEW YORK, September 17 (Reuters): Months in, the pandemic continues to take a toll on mental health. As part of our #AskReuters Twitter chat series, Reuters gathered a group of experts to share their
New Delhi, September 17 (IANS): A small yet significant study from China has found that people who wear eyeglasses may be at a lower risk of contracting Covid-19 as the virus may enter the body via eyes. The
London, September 17 (IANS): Smoking most likely has a significant share in all cases of subarachnoid haemorrhage, the most fatal type of cerebrovascular disturbances in the brain, warn researchers. The stud
SHANGHAI/SINGAPORE, September 16 (Reuters) - China is inoculating tens of thousands of its citizens with experimental coronavirus vaccines and attracting international interest in their development, despite exp
New Delhi, September 15 (ANI): The Indian Council of Medical Research DG Dr Balram Bhargava said on Tuesday said that re-infection with coronavirus is very rare. "Re-infection is very rare with COVID-19
New York, September 15 (IANS): Even as the world is rushing for solutions to fight Covid-19, developing and manufacturing vaccines will not end the pandemic quickly unless they are delivered equitably, warn Bil
New Delhi, September 15 (PTI): Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with ICMR and Cadila Hea
